1Y Annualised Return
▼-44.32%
3Y Annualised Return
▼-5.88%
5Y Annualised Return
▼-21.58%
10Y Annualised Return
▲18.82%
Genpharmasec Stock Performance
|
|
|
Genpharmasec Company background
Founded in: 1992
Genpharmasec Limited was originally incorporated as Public Limited Company on 16th November, 1992 in Gujarat as Adi Rasayan Limited. The Company had received Certificate for Commencement of Business from ROC, Gujarat on November 20, 1992. Further, the name of Company was changed from Adi Rayasan Limited to Genpharmasec Limited on 27 November, 2018. Thereafter, the name of the Company was once again changed from Generic Pharmasec Limited to Genpharmasec Limited on 25 October, 2021 a fresh Certificate of Incorporation upon the name change was obtained from the Registrar of Companies at Mumbai. The company is dealing primarily in pharmaceutical activities / services and trading in equity shares. The Company implemented a project to manufacture organic and inorganic chemicals, dyes and pigments, at Panoli, Gujarat. Initially, it started as a manufacturer and trader of organic and inorganic chemicals, dyes and pigments and from 2018 onwards, it shifted business activities to buying, selling and distribution of all kinds of pharmaceutical, medicinal and medicated preparations and decided to venture into the securities market. In 2019, Company focused to the lucrative medical and diagnostics device segment. The Company tied up with Abbott Point of Care Corporation INC, USA for distribution of their niche diagnostic equipment namely, iSTAT 1 Analyzer which is a handheld blood analyzer exclusively used in ICUs and ICCUs of hospitals for immediate test results.In FY 202324, Company has obtained distribution rights from Abbott Point of Care, USA for distribution of their iSTAT Analysers and its Cartridges all over India. The Directors of the Company are consistently making efforts to expand the business activities as depending exclusively one Company would result in stagnation of sales in the coming years. Besides these efforts, Company has started directly importing Cartridges from Abbott POC, USA which has increased its profitability to a great extent.
Genpharmasec Financial Highlights
For the full year FY2025–2026, revenue
reached ₹36.78 crore and profit touched at
₹1.23 crore.
As of 29 Aug, 2025, Genpharmasec share price is ₹1.9. The stock opened at ₹2 and had closed at ₹2 the previous day. During today’s trading session, Genpharmasec share price moved between ₹1.92 and ₹2.00, with an average price for the day of ₹1.96. Over the last 52 weeks, the stock has recorded a low of ₹1.84 and a high of ₹4.32. In terms of performance, Genpharmasec share price has declined by 4.4% over the past six months and has declined by 44.32% over the last year.
Genpharmasec SIP Return Calculator
Over the past
1 year
3 years
5 years
Total Investment of ₹65,00,000
Would have become ₹52,45,365 (-19.30%)
Daily SIP of ₹25,000 would have become ₹52,45,365 in 1 year with a gain of ₹-12,54,634 (-19.30%)
Genpharmasec Fundamental
Market Cap (in crs)
107.42
Face Value
1
Turnover (in lacs)
13.34
Key Metrics
Qtr Change %
55.09% Fall from 52W High
-8.9
Dividend yield 1yr %
0
Genpharmasec Key Financials
Loading chart...
Loading chart...
Loading chart...
Loading chart...
Genpharmasec Quarterly Revenue
| Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 |
|---|---|---|---|---|
12.04 Cr | 14.01 Cr | 8.48 Cr | 6.03 Cr | 5.19 Cr |
Genpharmasec Yearly Revenue
| Mar 2025 | Mar 2024 |
|---|---|
36.78 Cr | 31.06 Cr |
Genpharmasec Quarterly Net Profit/Loss
| Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 |
|---|---|---|---|---|
1.22 Cr | -0.27 Cr | 0.78 Cr | 0.7 Cr | 0.29 Cr |
Genpharmasec Yearly Net Profit/Loss
| Mar 2025 | Mar 2024 |
|---|---|
1.23 Cr | -0.17 Cr |
Genpharmasec Technical Analysis
Moving Averages Analysis
Moving Averages Analysis
1.94
Current Price
5Day EMA
2.00
10Day EMA
2.00
12Day EMA
2.00
20Day EMA
2.00
26Day EMA
2.00
50Day EMA
2.00
100Day EMA
2.10
200Day EMA
2.30
5Day SMA
2.00
10Day SMA
2.00
20Day SMA
2.00
30Day SMA
2.00
50Day SMA
2.00
100Day SMA
2.10
150Day SMA
2.10
200Day SMA
2.40
Delivery & Volume
| Period | Combined Delivery Volume | NSE+BSE Traded Volume |
|---|---|---|
Day Rs | 594009 Rs | 687813 Rs |
Week Rs | 429751 Rs | 495789 Rs |
Month Rs | 407091 Rs | 498033 Rs |
Resistance & Support
1.95
Pivot
Resistance
First Resistance
1.99
Second Resistance
2.03
Third Resistance
2.07
Support
First Support
1.91
Second support
1.87
Third Support
1.83
Relative Strength Index
41.28
Money Flow Index
39.25
MACD
-0.01
MACD Signal
-0.01
Average True Range
0.08
Average Directional Index
17.97
Rate of Change (21)
-2.02
Rate of Change (125)
-10.19
Genpharmasec Peer comparison
| Index Name | Market Price | Market Cap | 52W Low | 52W High | Prev. Close | 1W Return | 1M Return | 6M Return | 1Y Return | 3Y Return | Dividend Yield | PE Ratio | Industry PE | PB Ratio |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
148.95 | 87.89 | 122 | 230 | 147.10 | -0.03% | -0.07% | 4.34% | -10.84% | -1.91% | 0.00% | 15.73 | 40.09 | 1.57 | |
9.73 | 109.47 | 6.4 | 15.89 | 10.24 | -18.37% | 1.88% | 39.40% | 32.74% | 23.32% | 0.00% | 3.96 | 31.68 | 1.07 | |
324.95 | 100.40 | 302.05 | 646 | 318.00 | 0.60% | -6.31% | -9.96% | -24.65% | -55.36% | 0.31% | 20.84 | 40.09 | 1.40 | |
845.00 | 101.40 | 736 | 1190 | 843.70 | 0.12% | -3.82% | 2.05% | -20.65% | 87.49% | 0.41% | 26.89 | 40.09 | 1.89 | |
Zenith Drugs Ltd. | - | 68.55 | - | - | - | - | - | - | - | - | - | - | - | - |
55.77 | 111.56 | 55 | 104.9 | 57.50 | -8.42% | -9.02% | -37.62% | 0.00% | 0.00% | 0.00% | 10.40 | 40.09 | 1.61 |
Genpharmasec Share Price FAQs
How to buy Genpharmasec shares?
You can easily buy Genpharmasec shares in Kotak Securities by opening a demat account and getting the KYC documents verified online.
What is the 52-week high and low of Genpharmasec ?
The 52-week high and low of Genpharmasec share price is ₹4.32 and ₹1.84 as of 29/8/2025.
Please be aware that Genpharmasec stock prices are subject to continuous fluctuations due to various factors.
Open Demat Account